Silexion Therapeutics Corp (SLXN) scores 37 out of 100 on boothcheck's 11-model valuation framework. Verdict: Bad The estimated fair value is 14.8, representing a 1233% margin of safety. Quantitative score: 38/100. Qualitative score: 70/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.